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Healthcare data will soon be accessible using standard, open software interfaces. Here, we describe how
these interfaces could lead to improved healthcare by facilitating the development of software applications
(apps) that can be shared across physicians, health care organizations, translational researchers, and pa-
tients. We provide recommendations for next steps and resources for the myriad stakeholders. If challenges
related to efficacy, accuracy, utility, safety, privacy, and security can be met, this emerging apps model for
health information technology will open up the point of care for innovation and connect patients at home to
their healthcare data.Six years into the US government’s plan
to spend $48 billion dollars on information
technology for healthcare (health IT), elec-
tronic health records (EHRs) are about to
be widely connected to modern-day soft-
ware applications (apps) running on the
web, local intranets, or mobile devices.
These apps will give new life to data
entered into EHRs and other health IT
platforms by providing the ability to visu-
alize risks, trends, and trajectories; mash
up clinical records with external data
sources; and deliver decision support to
clinicians and patients during and be-
tween encounters. Apps will also create
new flows of data from sensors, devices,
and patient reports into EHRs. This tec-
tonic shift toward 21st century IT, which
mirrors changes sweeping across other
industries, will change the experience of
physicians and patients, dramatically
increasing return on EHR investments.
These shifts are occurring world-wide,
with the first effects likely to be seen in
the U.S. where the meaningful use pro-
gram for certification of health IT (Blumen-
thal, 2009) drove substantial adoption of
EHRs (Wright et al., 2013).
Beyond the Limitations of EHRs
EHRs principally show a doctor informa-
tion she entered previously, but not the
wide range of data and services that
should drive cost-efficient care and
decision making. Most healthcare
organizations limit the technology plat-
forms a physician must use—often to a
single, recently purchased EHR—largely8 Cell Systems 1, July 29, 2015 ª2015 Elsevibecause integration with the EHR after
purchase is an expensive, slow process
that must be repeated for each new
customer and each product. This
walled-off market has posed insurmount-
able barriers to entry for startups and
larger firms alike. It has also limited physi-
cians’ ability to customize EHRs in ways
that improve care or workflows.
An apps layer will open the clinical
encounter to third-party IT innovation.
Often those third parties will be the health-
care personnel using the EHR-driven
transactions and data in a way that others
had not imagined. Fostering third party
apps creates a market where innovations
compete with each other for purchase
and use by providers (and patients), thus
reducing dependency on updates and
specific functions made by an EHR
vendor. Many vendors now see that
nurturing this app ecosystem is essential
to both continuous improvement of EHR
modules and addressing the myriad
specialized needs of our complex health-
care delivery system (Halamka, 2014).
Developing apps and integrating them
for use solely with a particular EHR sys-
tem may be done by EHR vendors. But
this may not be the best outcome for
many functions, such as automated
dissemination of triage protocols in a
spreading epidemic (Mandl, 2014) or
genomic test interpretation, where
authoritative rapid dissemination of prac-
tice are in the patients’ best interest. In
these cases, it may be more effective for
an app to be implemented by one of theer Inc.many smaller vendors constituting the
long tail of the market’s curve rather
than only by one of the few dominant
EHR companies.
Precision Medicine: An Illustrative
Use Case
In his 2015 State of the Union Address,
President Obama announced his preci-
sion medicine initiative to develop the sci-
ence and evidence needed to personalize
treatment decisions for patients in
everyday practice. The first step in the
initiative will be to recruit a cohort of a
million patients consenting to be exten-
sively characterized by whole-genome
sequencing, RNA expression, and behav-
ioral data all linked to their EHRs (Collins
and Varmus, 2015). Similar to what was
proposed in a 2011 landmark National
Academy of Sciences report (National
Academy of Sciences, 2011), these data
would underpin a new taxonomy of dis-
ease, derived empirically from associa-
tions between genotypes and pheno-
types. This new taxonomy sharply
contrasts with the contemporary Interna-
tional Classification of Disease (ICD)-9
and ICD-10 systems, which are based
on symptoms, microscopic pathology,
and laboratory data.
Appropriately, these bold initiatives
focus on data collection, discovery, and
analysis—the ‘‘afferent limb’’ of precision
medicine. There is ample precedent for
linkage of EHR and genomic data to
rapidly build upon. The National Human
Genome Research Institute’s eMERGE
Box 1. Wearables and Continuous Sensors
The largest source of individual health data is likely to be from sensors that record information about a person continuously for days
or even years. Many such sensors are being integrated into wearable devices to measure heart rate and movement or into objects
in the environment, such as beds in a hospital’s intensive care unit that measure intracranial pressure or beds at home that record
sleep-time activity. Whether or not these data find their way to the institutional EHR or specialized storage for streamed data, cli-
nicians and patients will expect to be able to view derived and or summary measures and also have decision support (e.g., alerts)
driven from the primary or derived data. In principle, this task is no different than displaying or interpreting any other data in an EHR.
However, the reality of the growth in the ‘‘wearables’’ industry (e.g., Fitbit or Apple Watch) has vastly outstripped any standard-
ization efforts (Redmond et al., 2014), which suggests that the initial sets of apps for these data streamswill remain confined to their
respective platforms and also integrate with EHR data in very limited ways. Patient-driven open data efforts (Chiauzzi et al., 2015)
may be required to enforce cross-platform standardization.
Implementation of third party apps on an EHR platform will certainly raise a host of new issues regarding who pays for
the apps and who vets or regulates them. Specifically who will be responsible for their accuracy, reliability, data security, and
compliance with privacy regulation? Answers will be determined by who uses the apps and the particular context in which
there are used. At this time, despite the emergence of apps in the healthcare work environment, these questions are largely
unresolved.
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study cohorts of patients with bio-
specimens linked to EHRs (McCarty
et al., 2011). And even though EHRs are
not designed to be used as input for
data analytic engines, methods have
been developed to extract, transform,
and load EHR data into research plat-
forms such as i2b2, which underpins na-
tional multicenter efforts in clinical and
translational research (Mandl et al.,
2014; Masys et al., 2012).
Translating this knowledge into clinical
practice—the ‘‘efferent limb’’ of precision
medicine—reveals the limitations of cur-
rent EHR systems. How will the innova-
tions from the President’s initiative reach
the doctor and the patient, and how will
the new data types needed for precision
medicine be integrated into medical deci-
sion making? EHRs are not designed for
storage or display of genomic data nor
for the computation that will no doubt be
needed to eventually tailor therapy to a
patient’s genome.
Advancing Healthcare with Apps
Robust healthcare apps would facilitate
the delivery of services that should be
the lifeblood of accountable healthcare
organizations seeking to improve care
and reduce cost. In addition to precision
medicine, apps could be used for popula-
tion health analytics, integration of data
from multiple devices that track fitness
and activity, monitoring and improvement
ofmedication adherence, chronic disease
management, and identification of high-
risk and high-cost patients and coordina-
tion of their care. Unlocking these ser-vices at national scale, without deep
one-off integrations, would facilitate the
work of public health agencies, enabling
them to reliably alert clinicians about in-
fectious diseases (Mandl, 2014) or post-
market medication safety concerns.
An apps ecosystem could also advance
healthcare by merging the clinical and
research missions with tools that match
patients to, and engage them in, clinical
trials. The first apps based on Apple’s
recently released ResearchKit software
framework use modular consent and mo-
bile data collection to make clinical trials
accessible to anyone with an iPhone.
And Apple’s HealthKit framework that
centralizes storage and enables sharing
of data from health and fitness apps,
or something similar, could ultimately
become a standard interface to a pa-
tient’s medical devices, such as glucome-
ters and cardiac monitors as well as sen-
sors and wearables (Box 1).
Opening the healthcare encounter to
apps would increase the impact of the
Affordable Care Act by facilitating delivery
of cost data to ordering physicians, sup-
porting price transparency, and enabling
automated identification of high-risk,
high-cost patients for case management.
Because no one solution will fit all, an
ecosystem of diverse apps will make it
easier to experiment with a far wider
range of patient-management options.
This breadth is necessary if healthcare is
to be transformed much more efficiently.
Ultimately, the ecosystem will comprise
innovative third party apps that run for
the physician in the context of an EHR,
mobile apps that extend physician’sCell Systworkspace, and mobile apps that bi-di-
rectionally connect delivery system data
to mobile apps that reach the patient.
An appsmodel enables rich data visual-
ization well beyond the capabilities of any
existing EHR. The value of this function
alone cannot be underestimated. At Bos-
ton Children’s Hospital, an app for man-
aging hypertension, which simply dis-
plays a child’s blood pressure over time
adjusted for age by percentile, has been
used tens of thousands of times over the
past two years. As discussed below, a
public software interface to health system
data will enable deployment of this and
other apps not as one-off projects but uni-
versally across healthcare settings.
Apps also permit integration of ‘‘big da-
ta’’(Weber et al., 2014) from external sour-
ces—such as massive payor databases
covering hundreds of millions of individ-
uals, genomes inexpensively stored on
the Google cloud (Regalado, 2014), or
data from public health surveillance sys-
tems (Mandl, 2014)—to the point of care
to drive decision making.
Hello APIs
An ecosystem of apps should be based
on free, open healthcare application pro-
gramming interfaces (APIs) that define
how apps can connect to any EHR or
data warehouse (Figure 1). In a report in
2009 (Mandl and Kohane, 2009), we
made an analogy to the consumer tech-
nology space, where smartphones offer
well-specified APIs to software devel-
opers, enabling an app market with
incredible diversity and quality. Impor-
tantly, healthcare APIs would enableems 1, July 29, 2015 ª2015 Elsevier Inc. 9
Figure 1. Creating an Ecosystem for Apps
The lower panel shows a classic EHR with a standard view of the data. Above is shown an ecosystem of apps supported by a uniform public application pro-
gramming interface for healthcare data. A third party app written once can run anywhere. The app can be reused on multiple EHRs and other forms of health
information technology. The end user can select apps from a gallery or ‘‘app store’’ and, just as on a smart phone, one app can be readily be substituted for
another. Image courtesy of Rachel Eastwood.
10 Cell Systems 1, July 29, 2015 ª2015 Elsevier Inc.
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can be readily added to or deleted from
an EHR or a mobile device that draws
data from an EHR. Substitutability en-
ables a tailored end-user experience—
contrasting with today’s one-size-fits-all
approach, in which gynecologists and
dermatologists share the same EHR
experience (or where specialists pur-
chase custom full-stack products that
integrate poorly across delivery systems).
Substitutable apps in healthcare are no
longer science fiction, and a wave of ac-
tivity around both technology and regula-
tion is accelerating their adoption (Fisher,
2014; JASON and The Mitre Corporation,
2014). Major healthcare systems are im-
plementing APIs on their EHRs. And pro-
posed language for meaningful use stage
3—the U.S. regulations specifying re-
quirements for health IT certification and
consequent Centers for Medicare and
Medicaid Services (CMS) payment—spe-
cifically embraces APIs as a strategy for
engaging patients and enabling ‘‘data
portability’’ for providers. To implement
such APIs, technologists are converging
on Health Level 7’s (HL7’s) Fast Health-
care Interoperability Resources (FHIR),
an emerging draft data standard that
greatly facilitates agreement about how
to exchange healthcare data.
Taking up themantle, the leading health
data standards organization, several fed-
eral IT committee co-chairs, multiple ma-
jor delivery systems, five major EHR ven-
dors, and the SMART team that we lead
recently joined forces in a project called
Argonaut (Halamka, 2014) to initiate pilots
supporting uptake of healthcare APIs and
driving their possible inclusion in mean-
ingful use regulation. To create an app
that runs anywhere, an app developer
must know precisely what to expect
when making a data request. If an app
asks for the medication list, the system
should respond uniformly and consis-
tently. The app developer should not
need to know how the underlying data
are stored or which brand of EHR it is
running on. A standard, public, open API
will define a new form of interoperability
across systems.
Implications for Providers, Patients,
and Researchers
How much does this techno-nerd
tinkering and policy plotting matter to
the average physician, health care organi-zation, or translational researcher? A lot.
Although it is now virtually inevitable
that, as we recommended 6 years ago
(Mandl and Kohane, 2009), many EHR
vendors will implement APIs allowing ac-
cess to health system data by third party
apps (Epic recently announced that they
will support an apps exchange [Mone-
gain, 2015]), the devil is in the details.
Worryingly, the ultimate benefit to the
health system and physicians could vary
widely, depending on how these APIs
are implemented and whether customers
of health IT become educated and
exacting. If the health system can
respond in a coordinated fashion, there
will be a core set of open, widely adopted,
well-specified APIs that allow apps to run
across diverse health IT systems, creating
tremendous economies of scale. But if we
lose focus on this goal, the functionality of
EHRs may improve, but the large market
may never materialize to incentivize inno-
vation, or app developers may need to
create multiple different versions of each
app for different EHR systems.
Patients will benefit from a uniform API
that enables a new and different genera-
tion of mobile apps. The vast majority of
the mobile apps currently available to
smartphone users are disconnected
from the care delivery system. With a uni-
form, public, standardized API, mobile
apps can request data from the health-
care delivery system, and ultimately also
write data back into EHRs and other forms
of health IT. Data from sensors, devices,
and wearables will be ‘‘mashed up’’ with
clinical data such as laboratories and ra-
diographs, and will also be written back
into the official electronic record.
With a core set of common APIs, apps-
based competition will drive robust,
healthymarket forces. Physicians and pa-
tients will enjoy a rich and ever-evolving
ecosystem of apps, and they, rather
than only technology vendors or govern-
ment committees, will decide which
health IT products are beneficial and
valuable.
Immediate Next Steps
Physicians, practices, and larger health-
care delivery organizations, when seeking
to purchase or renew contracts for health
IT, should adopt common RFP language
(Table 1), specifying and requiring inclu-
sion of a uniform healthcare API. The
SMART API, based on open standardsCell Systeincluding FHIR, OAuth2, OpenID Con-
nect, RxNorm, SNOMED, and LOINC, is
a good place to start. They should begin
to hire app developers, partner with tech-
nology companies, or watch the market
for new products.
Health IT vendors should continue to
voluntarily adopt open health data API
standards and implement these stan-
dards in their products. Vendors should
provide tools and infrastructure to sup-
port self-service registration of applica-
tions (as on smartphones).
Software developers, public health
agencies, payors, pharma, and startups
should request access to health system
data through common, open APIs,
instead of via expensive and often unten-
able one-off integrations.
Policymakers at the Office of the Na-
tional Coordinator of Health Information
Technology (ONC) and Centers for Medi-
care and Medicaid Services, if the mean-
ingful use program is continued, should
restrict future certification requirements
to functionality implementable through
EHR apps using a common, open set of
healthcare APIs.
Research agencies, including the NIH,
should fund researchers developing
point-of-care innovations not to create
one-off efforts fit to the peculiarities of in-
dividual healthcare institutions, but rather
as generalizable applications that can run
widely and transform healthcare.
Fostering Quality
At first blush, a free market for apps that
encourages innovation and competition
among companies and other contributors
might seem best. However, even in the
enormously successful Google Play and
Apple App Stores, the medical apps are
highly variable in quality, utility, and
safety. The popular and lucrative apps
are not necessarily the best or the most
effective. Regulation and quality stan-
dards from one source, such as the gov-
ernment, often can result in inflexibility
and slow progress. So how can we navi-
gate between free market and the quality
that we hope all apps will meet at
minimum?
First and foremost, physicians, pa-
tients, and organizations running apps
must be assured that the apps they run
are safe and non-malicious. The US
Food and Drug Administration’s (FDA)
foray into mobile medical app regulationms 1, July 29, 2015 ª2015 Elsevier Inc. 11
Table 1. Resources for App Builders
Resource URL
FHIR API http://hl7.org/fhir/ A resource-oriented healthcare API providing about
100 resource definitions, including clinical,
administrative, and financial data, as well as a REST
API defining Create, Read, Update, Delete, and Search
functionality.
SMART API http://docs.smarthealthit.org/ A health app platform based on open standards
including FHIR for clinical data, OAuth 2.0 for
authorization, OpenID Connect for single sign-on, and
HTML5 for embedding apps inside of an EHR.
Research Kit https://www.apple.com/researchkit/ An open-source framework that enables the
development of apps for medical research, including
consent workflows and data collection.
Health Kit https://developer.apple.com/healthkit/ An iOS Core Framework for managing personal health
data with a focus on measured quantities (e.g., step
counts, home glucose readings, blood pressures).
Google Fit API https://developers.google.com/fit/ A set of Android APIs for capturing and querying
fitness-related sensor data including calories steps,
calories burned, and nutrients consumed.
Validic API http://validic.com/api An aggregated API that normalizes and exposes data
from health and fitness devices and applications. Data
from multiple vendors are exposed in a consistent
format.
2net Platform http://www.qualcommlife.com/wireless-health A platform for aggregating device data with a focus
on wireless devices including glucose meters and
inhalers, with a standalone home-based hub that
aggregates and uploads data.
RFP Language for Buying
API-enabled HIT
http://smarthealthit.org/2014/10/rfp-language-for-
buying-smart-compatible-hit/
A set of recommendations for organizations
purchasing health IT systems, with a focus on
providing support for standards-based third-party
app integration.
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(Thompson and Brodsky, 2013). It ap-
pears that the agency will concentrate
on apps that function as an accessory to
a currently regulated medical device or
which will effectively transform a tablet
or smartphone into a regulated medical
device (McCarthy, 2013). But even as
the FDA backs down on regulation, the
US Federal Trade Commission is cracking
down on apps making unsubstantiated
medical claims (Saxena, 2015).
Regulated or not, because apps will
require access to health system data,
they must be must be vetted not only for
efficacy, but also for accuracy, utility,
safety, privacy, and security. There will
no doubt be calls for a formal certification
process, but in the past, a single point of
certification for health IT came under
scrutiny for being too closely tied to in-
dustry (DoBias, 2006). End-users would
be better served by a systemwith familiar,
trusted sources of authority, including
professional society seals of approval,
patient and physician ratings, and quality12 Cell Systems 1, July 29, 2015 ª2015 Elsevchecks and validations by expert
organizations.
A major challenge now for a developer
of apps outside the major health IT ven-
dors is that they tend to lack access to
high quality health system data for devel-
opment and validation (Taylor and Mandl,
2015). Another is that most health IT ven-
dors have generally pushed liability onto
the health system users of the products
(Koppel and Kreda, 2009), and it can be
expected that app vendors will be asked
to asymmetrically take on risk and provide
indemnification. But clearly, in an apps-
based health IT economy, there will be
opportunities for alternative approaches
that would improve product safety,
including open and public sharing of
data on performance and harms.
Standards for handling data privacy
and security (Sunyaev et al., 2015) as
well as rules for ‘‘good’’ app behavior
will need to be developed—for example,
an app should request the minimum data-
set required to perform its function. And,
in contrast to the vast majority of health-ier Inc.care apps currently available for smart
phones, clear and accurate privacy pol-
icies should be available to guide selec-
tion (Sunyaev et al., 2015).
Because the app may run on a com-
puter outside the home institution housing
the EHR, Health Insurance Portability and
Accountability (HIPAA) business asso-
ciate agreements (BAAs) may need to be
in place between the apps company and
the clinical entity running the app.
Ultimately, EHRs and other forms of
digital health technology that can provide
a highly usable apps framework, enabling
concurrent use of apps selected from
a variety of ‘‘best of breed’’ sources will
be strongly advantaged in the market-
place. Vendors wishing to transform their
EHR products into robust apps platforms
may need to retool their products to
support API calls and with sub-second
response times. Recognizing the difficulty
of doing so, startups are already arising
to create platforms that run apps on
high performance, distributed database
architectures with data extracted from
Cell Systems
CommentaryEHRs—what we call ‘‘side cars’’ (Mandl
et al., 2014).
Conclusion
The US healthcare system now has the
opportunity to widely implement substi-
tutable apps, shifting the paradigm for
sharing knowledge and know-how and
greatly accelerating healthcare reform
and efforts to contain cost. Currently, clin-
ical knowledge is shared through publica-
tions, guidelines, and consensus state-
ments triggering the beginning of long
adoption cycles for new advances. In
contrast, apps can transfer ideas, func-
tionality, and workflow all in one package.
A good app, distributed widely, could
reshape practice overnight. An innova-
tor’s idea, whether to improve care
through precision medicine or through
payment reform, becomes implement-
able at the point of care across the health-
care system. Agreement on, implementa-
tion of, and adherence to a standard,
public, free, and open API will promote a
new form of interoperability transforming
healthcare into a modular plug and play
system, dramatically increasing the rate
of progress while reducing the cost of
change.
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